Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 114

1.

Actively induced antigen-specific CD8+ T cells by epitope-bearing parasite pre-infection but not prime/boost virus vector vaccination could ameliorate the course of Plasmodium yoelii blood-stage infection.

Ono T, Yamaguchi Y, Oguma T, Takayama E, Takashima Y, Tadakuma T, Miyahira Y.

Vaccine. 2012 Sep 28;30(44):6270-8. doi: 10.1016/j.vaccine.2012.08.009. Epub 2012 Aug 16.

PMID:
22902783
2.

Quantitative and qualitative features of heterologous virus-vector-induced antigen-specific CD8+ T cells against Trypanosoma cruzi infection.

Takayama E, Ono T, Carnero E, Umemoto S, Yamaguchi Y, Kanayama A, Oguma T, Takashima Y, Tadakuma T, GarcĂ­a-Sastre A, Miyahira Y.

Int J Parasitol. 2010 Nov;40(13):1549-61. doi: 10.1016/j.ijpara.2010.05.011. Epub 2010 Jul 8.

3.

Generation of a recombinant single-chain variable fragment (scFv) targeting 5-methyl-2'-deoxycytidine.

Ohshima M, Tadakuma T, Hayashi H, Inoue K, Itoh K.

J Biochem. 2010 Jan;147(1):135-41. doi: 10.1093/jb/mvp151. Epub 2009 Oct 8.

PMID:
19815683
4.

CD4(+)CD8(+) thymocytes are induced to cell death by a small dose of puromycin via ER stress.

Oguma T, Ono T, Kajiwara T, Sato M, Miyahira Y, Arino H, Yoshihara Y, Tadakuma T.

Cell Immunol. 2009;260(1):21-7. doi: 10.1016/j.cellimm.2009.07.002. Epub 2009 Jul 14.

PMID:
19665696
5.

Adenylyl cyclase alpha and cAMP signaling mediate Plasmodium sporozoite apical regulated exocytosis and hepatocyte infection.

Ono T, Cabrita-Santos L, Leitao R, Bettiol E, Purcell LA, Diaz-Pulido O, Andrews LB, Tadakuma T, Bhanot P, Mota MM, Rodriguez A.

PLoS Pathog. 2008 Feb 29;4(2):e1000008. doi: 10.1371/journal.ppat.1000008.

7.

Plasmodium yoelii yoelii 17XNL constitutively expressing GFP throughout the life cycle.

Ono T, Tadakuma T, Rodriguez A.

Exp Parasitol. 2007 Mar;115(3):310-3. Epub 2006 Oct 17.

8.

Targeting gene therapy for prostate cancer cells by liposomes complexed with anti-prostate-specific membrane antigen monoclonal antibody.

Ikegami S, Yamakami K, Ono T, Sato M, Suzuki S, Yoshimura I, Asano T, Hayakawa M, Tadakuma T.

Hum Gene Ther. 2006 Oct;17(10):997-1005.

PMID:
17032155
9.
10.

Occurrence of pre-MBT synthesis of caspase-8 mRNA and activation of caspase-8 prior to execution of SAMDC (S-adenosylmethionine decarboxylase)-induced, but not p53-induced, apoptosis in Xenopus late blastulae.

Shiokawa K, Takayama E, Higo T, Kuroyanagi S, Kaito C, Hara H, Kajitani M, Sekimizu K, Tadakuma T, Miura K, Igarashi K, Yaoita Y.

Biochem Biophys Res Commun. 2005 Oct 21;336(2):682-91.

PMID:
16143307
11.

Selective gene therapy for prostate cancer cells using liposomes conjugated with IgM type monoclonal antibody against prostate-specific membrane antigen.

Ikegami S, Tadakuma T, Yamakami K, Ono T, Suzuki S, Yoshimura I, Asano T, Hayakawa M.

Hum Cell. 2005 Mar;18(1):17-23.

PMID:
16130896
12.

Regulation of the expression of caspase-9 by the transcription factor activator protein-4 in glucocorticoid-induced apoptosis.

Tsujimoto K, Ono T, Sato M, Nishida T, Oguma T, Tadakuma T.

J Biol Chem. 2005 Jul 29;280(30):27638-44. Epub 2005 Jun 8.

13.

Involvement of caspase-9 in execution of the maternal program of apoptosis in Xenopus late blastulae overexpressed with S-adenosylmethionine decarboxylase.

Takayama E, Higo T, Kai M, Fukasawa M, Nakajima K, Hara H, Tadakuma T, Igarashi K, Yaoita Y, Shiokawa K.

Biochem Biophys Res Commun. 2004 Dec 24;325(4):1367-75.

PMID:
15555578
14.
15.

Suppression of lung metastasis of renal cell carcinoma by the intramuscular gene transfer of a soluble form of vascular endothelial growth factor receptor I.

Yoshimura I, Mizuguchi Y, Miyajima A, Asano T, Tadakuma T, Hayakawa M.

J Urol. 2004 Jun;171(6 Pt 1):2467-70.

PMID:
15126877
16.

Treatment efficiency of a suicide gene therapy using prostate-specific membrane antigen promoter/enhancer in a castrated mouse model of prostate cancer.

Ikegami S, Tadakuma T, Ono T, Suzuki S, Yoshimura I, Asano T, Hayakawa M.

Cancer Sci. 2004 Apr;95(4):367-70.

17.

Protection against Leishmania major infection by oligomannose-coated liposomes.

Shimizu Y, Yamakami K, Gomi T, Nakata M, Asanuma H, Tadakuma T, Kojima N.

Bioorg Med Chem. 2003 Apr 3;11(7):1191-5.

PMID:
12628646
18.

Functional and Vbeta repertoire characterization of human CD8+ T-cell subsets with natural killer cell markers, CD56+ CD57- T cells, CD56+ CD57+ T cells and CD56- CD57+ T cells.

Takayama E, Koike Y, Ohkawa T, Majima T, Fukasawa M, Shinomiya N, Yamaguchi T, Konishi M, Hiraide H, Tadakuma T, Seki S.

Immunology. 2003 Feb;108(2):211-9.

19.

Repair of full-thickness cartilage defects using liposomal transforming growth factor-beta1.

Abe T, Yamada H, Nakajima H, Kikuchi T, Takaishi H, Tadakuma T, Fujikawa K, Toyama Y.

J Orthop Sci. 2003;8(1):92-101.

PMID:
12560894
20.

Adenovirus mediated prostate specific enzyme prodrug gene therapy using prostate specific antigen promoter enhanced by the Cre-loxP system.

Yoshimura I, Ikegami S, Suzuki S, Tadakuma T, Hayakawa M.

J Urol. 2002 Dec;168(6):2659-64.

PMID:
12442005
21.
22.

Nuclear translocation of extracellular superoxide dismutase.

Ookawara T, Kizaki T, Takayama E, Imazeki N, Matsubara O, Ikeda Y, Suzuki K, Li Ji L, Tadakuma T, Taniguchi N, Ohno H.

Biochem Biophys Res Commun. 2002 Aug 9;296(1):54-61.

PMID:
12147226
23.

Different role of Apaf-1 in positive selection, negative selection and death by neglect in foetal thymic organ culture.

Matsuki Y, Zhang HG, Hsu HC, Yang PA, Zhou T, Dodd CH, Cecconi F, Gruss P, Tadakuma T, Mountz JD.

Scand J Immunol. 2002 Aug;56(2):174-84.

25.

Liposome-mediated gene therapy using HSV-TK/ganciclovir under the control of human PSA promoter in prostate cancer cells.

Suzuki S, Tadakuma T, Kunitomi M, Takayama E, Sato M, Asano T, Nakamura H, Hayakawa M.

Urol Int. 2001;67(3):216-23.

PMID:
11598449
26.

Suicide gene therapy on LNCaP human prostate cancer cells.

Yoshimura I, Suzuki S, Tadakuma T, Hayakawa M.

Int J Urol. 2001 Jul;8(7):S5-8.

27.
28.

Mice lacking protein tyrosine kinase fyn develop a T helper-type 1 response and resistLeishmania major infection.

Yamakami K, Akao S, Wakabayashi K, Tadakuma T, Yoshizawa N.

Environ Health Prev Med. 2001 Jul;6(2):132-5. doi: 10.1007/BF02897960.

30.

Expression of carbonic anhydrase I or II and correlation to clinical aspects of colorectal cancer.

Bekku S, Mochizuki H, Yamamoto T, Ueno H, Takayama E, Tadakuma T.

Hepatogastroenterology. 2000 Jul-Aug;47(34):998-1001.

PMID:
11020863
31.

Inhibition of glucocorticoid-induced apoptosis by the expression of antisense gene of mitochondrial ATPase subunit 6(1).

Sato M, Matsuki Y, Oguma T, Tsujimoto K, Takayama E, Tadakuma T.

FEBS Lett. 2000 Jul 28;478(1-2):34-8.

32.

Mouse CD8+ CD122+ T cells with intermediate TCR increasing with age provide a source of early IFN-gamma production.

Takayama E, Seki S, Ohkawa T, Ami K, Habu Y, Yamaguchi T, Tadakuma T, Hiraide H.

J Immunol. 2000 Jun 1;164(11):5652-8.

33.

The potential role for nephritis-associated plasmin receptor in acute poststreptococcal glomerulonephritis.

Yamakami K, Yoshizawa N, Wakabayashi K, Takeuchi A, Tadakuma T, Boyle MD.

Methods. 2000 Jun;21(2):185-97.

PMID:
10816380
34.

Selective inhibition of hepatoma cells using diphtheria toxin A under the control of the promoter/enhancer region of the human alpha-fetoprotein gene.

Kunitomi M, Takayama E, Suzuki S, Yasuda T, Tsutsui K, Nagaike K, Hiroi S, Tadakuma T.

Jpn J Cancer Res. 2000 Mar;91(3):343-50.

35.

Cell-specific expression of the diphtheria toxin A-chain coding sequence under the control of the upstream region of the human alpha-fetoprotein gene.

Murayama Y, Tadakuma T, Kunitomi M, Kumai K, Tsutsui K, Yasuda T, Kitajima M.

J Surg Oncol. 1999 Mar;70(3):145-9.

PMID:
10102343
36.

Enhancement of activation-induced cell death by fibronectin in murine CD4+ CD8+ thymocytes.

Takayama E, Kina T, Katsura Y, Tadakuma T.

Immunology. 1998 Dec;95(4):553-8.

37.

Carbonic anhydrase I and II as a differentiation marker of human and rat colonic enterocytes.

Bekku S, Mochizuki H, Takayama E, Shinomiya N, Fukamachi H, Ichinose M, Tadakuma T, Yamamoto T.

Res Exp Med (Berl). 1998 Dec;198(4):175-85.

PMID:
9879596
38.

Inhibitory effect of protease inhibitor on endothelial cell activation.

Aosasa S, Ono S, Seki S, Takayama E, Tadakuma T, Hiraide H, Mochizuki H.

J Surg Res. 1998 Dec;80(2):182-7.

PMID:
9878311
39.

Cloning and expression of an alpha-2,8-polysialyltransferase (STX) from Xenopus laevis.

Kudo M, Takayama E, Tashiro K, Fukamachi H, Nakata T, Tadakuma T, Kitajima K, Inoue Y, Shiokawa K.

Glycobiology. 1998 Aug;8(8):771-7.

PMID:
9639538
40.

Molecular cloning of ssd-form neural cell adhesion molecules (N-CAMs) as the major form in Xenopus heart.

Kudo M, Takayama E, Tadakuma T, Shiokawa K.

Biochem Biophys Res Commun. 1998 Apr 7;245(1):127-32.

PMID:
9535795
41.

[Molecular mechanism of apoptosis operated in the immune system].

Tadakuma T.

Nihon Rinsho. 1997 Jun;55(6):1337-44. Review. Japanese.

PMID:
9200915
42.

Improvement of pharmacokinetics and antitumor activity against human hepatoma cell line by using adriamycin-entrapped stealth liposomes.

Shimizu H, Kumai K, Uyama I, Shibata S, Tagawa T, Nagaike K, Yasuda T, Kitajima M, Tadakuma T.

J Surg Oncol. 1996 Jul;62(3):186-93.

PMID:
8667626
43.

Antibody specific for phosphorylated AMPA-type glutamate receptors at GluR2 Ser-696.

Nakazawa K, Tadakuma T, Nokihara K, Ito M.

Neurosci Res. 1995 Dec;24(1):75-86.

PMID:
8848293
44.
45.

Single-cell observation of calcium signals in T cells and antigen-presenting cells during antigen presentation.

Torigoe C, Tadakuma T, Nakanishi M.

Immunol Lett. 1995 May;46(1-2):75-9.

PMID:
7590932
46.

In vivo function of homing receptors participating in lymphocyte recirculation: transfer analysis in SCID mice.

Saito S, Kuwashima N, Koizumi H, Nomura T, Yagita H, Okumura K, Sonoda A, Tadakuma T, Tanaka H.

Pathobiology. 1995;63(6):305-13.

PMID:
8738469
47.

Naive T cells can mediate delayed-type hypersensitivity response in T cell receptor transgenic mice.

Sato T, Sasahara T, Nakamura Y, Osaki T, Hasegawa T, Tadakuma T, Arata Y, Kumagai Y, Katsuki M, Habu S.

Eur J Immunol. 1994 Jul;24(7):1512-6.

PMID:
8026513
48.

Acceleration of diabetes in young NOD mice with peritoneal macrophages.

Shimada A, Takei I, Maruyama T, Kasuga A, Kasatani T, Watanabe K, Asaba Y, Ishii T, Tadakuma T, Habu S, et al.

Diabetes Res Clin Pract. 1994 Jun;24(2):69-76.

PMID:
7956711
49.
50.

[Apoptosis in immunology].

Tadakuma T.

Gan To Kagaku Ryoho. 1994 Apr;21(5):608-14. Review. Japanese.

PMID:
7512321

Supplemental Content

Loading ...
Support Center